ReviewFree radical biology & medicine2021

Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19.

Joe M McCord et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.